Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2025(Status and Outlook)
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
The global Nuclear Medicine Radiopharmaceuticals market size was estimated at USD 6663.34 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclear Medicine Radiopharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclear Medicine Radiopharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclear Medicine Radiopharmaceuticals market.
Global Nuclear Medicine Radiopharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng
Market Segmentation (by Type)
Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Market Segmentation (by Application)
Oncology
Thyroid
Cardiology
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclear Medicine Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Nuclear Medicine Radiopharmaceuticals market size was estimated at USD 6663.34 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclear Medicine Radiopharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclear Medicine Radiopharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclear Medicine Radiopharmaceuticals market.
Global Nuclear Medicine Radiopharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng
Market Segmentation (by Type)
Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Market Segmentation (by Application)
Oncology
Thyroid
Cardiology
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nuclear Medicine Radiopharmaceuticals Market
- Overview of the regional outlook of the Nuclear Medicine Radiopharmaceuticals Market:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclear Medicine Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nuclear Medicine Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Nuclear Medicine Radiopharmaceuticals Segment by Type
1.2.2 Nuclear Medicine Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Nuclear Medicine Radiopharmaceuticals Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nuclear Medicine Radiopharmaceuticals Product Life Cycle
3.3 Global Nuclear Medicine Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Nuclear Medicine Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Nuclear Medicine Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nuclear Medicine Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nuclear Medicine Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Nuclear Medicine Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nuclear Medicine Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Medicine Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nuclear Medicine Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nuclear Medicine Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Type (2020-2025)
6.4 Global Nuclear Medicine Radiopharmaceuticals Price by Type (2020-2025)
7 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Radiopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Nuclear Medicine Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Nuclear Medicine Radiopharmaceuticals Sales by Region
8.1.1 Global Nuclear Medicine Radiopharmaceuticals Sales by Region
8.1.2 Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Region
8.2 Global Nuclear Medicine Radiopharmaceuticals Market Size by Region
8.2.1 Global Nuclear Medicine Radiopharmaceuticals Market Size by Region
8.2.2 Global Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Region
8.3 North America
8.3.1 North America Nuclear Medicine Radiopharmaceuticals Sales by Country
8.3.2 North America Nuclear Medicine Radiopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nuclear Medicine Radiopharmaceuticals Sales by Country
8.4.2 Europe Nuclear Medicine Radiopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales by Region
8.5.2 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nuclear Medicine Radiopharmaceuticals Sales by Country
8.6.2 South America Nuclear Medicine Radiopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Nuclear Medicine Radiopharmaceuticals by Region(2020-2025)
9.2 Global Nuclear Medicine Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Nuclear Medicine Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nuclear Medicine Radiopharmaceuticals Production
9.4.1 North America Nuclear Medicine Radiopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Nuclear Medicine Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nuclear Medicine Radiopharmaceuticals Production
9.5.1 Europe Nuclear Medicine Radiopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Nuclear Medicine Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nuclear Medicine Radiopharmaceuticals Production (2020-2025)
9.6.1 Japan Nuclear Medicine Radiopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Nuclear Medicine Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nuclear Medicine Radiopharmaceuticals Production (2020-2025)
9.7.1 China Nuclear Medicine Radiopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Nuclear Medicine Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cardinal Health
10.1.1 Cardinal Health Basic Information
10.1.2 Cardinal Health Nuclear Medicine Radiopharmaceuticals Product Overview
10.1.3 Cardinal Health Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Basic Information
10.2.2 GE Healthcare Nuclear Medicine Radiopharmaceuticals Product Overview
10.2.3 GE Healthcare Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Jubilant Pharma
10.3.1 Jubilant Pharma Basic Information
10.3.2 Jubilant Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
10.3.3 Jubilant Pharma Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.3.4 Jubilant Pharma Business Overview
10.3.5 Jubilant Pharma SWOT Analysis
10.3.6 Jubilant Pharma Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Nuclear Medicine Radiopharmaceuticals Product Overview
10.4.3 Novartis Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Curium Pharma
10.5.1 Curium Pharma Basic Information
10.5.2 Curium Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
10.5.3 Curium Pharma Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.5.4 Curium Pharma Business Overview
10.5.5 Curium Pharma Recent Developments
10.6 SIEMENS
10.6.1 SIEMENS Basic Information
10.6.2 SIEMENS Nuclear Medicine Radiopharmaceuticals Product Overview
10.6.3 SIEMENS Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.6.4 SIEMENS Business Overview
10.6.5 SIEMENS Recent Developments
10.7 Lantheus
10.7.1 Lantheus Basic Information
10.7.2 Lantheus Nuclear Medicine Radiopharmaceuticals Product Overview
10.7.3 Lantheus Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.7.4 Lantheus Business Overview
10.7.5 Lantheus Recent Developments
10.8 Bracco Imaging
10.8.1 Bracco Imaging Basic Information
10.8.2 Bracco Imaging Nuclear Medicine Radiopharmaceuticals Product Overview
10.8.3 Bracco Imaging Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.8.4 Bracco Imaging Business Overview
10.8.5 Bracco Imaging Recent Developments
10.9 Bayer
10.9.1 Bayer Basic Information
10.9.2 Bayer Nuclear Medicine Radiopharmaceuticals Product Overview
10.9.3 Bayer Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.9.4 Bayer Business Overview
10.9.5 Bayer Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Basic Information
10.10.2 Eli Lilly Nuclear Medicine Radiopharmaceuticals Product Overview
10.10.3 Eli Lilly Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.10.4 Eli Lilly Business Overview
10.10.5 Eli Lilly Recent Developments
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Basic Information
10.11.2 Aurobindo Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
10.11.3 Aurobindo Pharma Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.11.4 Aurobindo Pharma Business Overview
10.11.5 Aurobindo Pharma Recent Developments
10.12 Mundipharma
10.12.1 Mundipharma Basic Information
10.12.2 Mundipharma Nuclear Medicine Radiopharmaceuticals Product Overview
10.12.3 Mundipharma Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.12.4 Mundipharma Business Overview
10.12.5 Mundipharma Recent Developments
10.13 China Isotope and Radiation
10.13.1 China Isotope and Radiation Basic Information
10.13.2 China Isotope and Radiation Nuclear Medicine Radiopharmaceuticals Product Overview
10.13.3 China Isotope and Radiation Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.13.4 China Isotope and Radiation Business Overview
10.13.5 China Isotope and Radiation Recent Developments
10.14 Dongcheng
10.14.1 Dongcheng Basic Information
10.14.2 Dongcheng Nuclear Medicine Radiopharmaceuticals Product Overview
10.14.3 Dongcheng Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.14.4 Dongcheng Business Overview
10.14.5 Dongcheng Recent Developments
11 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast
11.2 Global Nuclear Medicine Radiopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Region
11.2.4 South America Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nuclear Medicine Radiopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Nuclear Medicine Radiopharmaceuticals Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Nuclear Medicine Radiopharmaceuticals by Type (2026-2033)
12.1.2 Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Nuclear Medicine Radiopharmaceuticals by Type (2026-2033)
12.2 Global Nuclear Medicine Radiopharmaceuticals Market Forecast by Application (2026-2033)
12.2.1 Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nuclear Medicine Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Nuclear Medicine Radiopharmaceuticals Segment by Type
1.2.2 Nuclear Medicine Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Nuclear Medicine Radiopharmaceuticals Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nuclear Medicine Radiopharmaceuticals Product Life Cycle
3.3 Global Nuclear Medicine Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Nuclear Medicine Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Nuclear Medicine Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nuclear Medicine Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nuclear Medicine Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Nuclear Medicine Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nuclear Medicine Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Medicine Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nuclear Medicine Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nuclear Medicine Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Type (2020-2025)
6.4 Global Nuclear Medicine Radiopharmaceuticals Price by Type (2020-2025)
7 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Radiopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Nuclear Medicine Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Nuclear Medicine Radiopharmaceuticals Sales by Region
8.1.1 Global Nuclear Medicine Radiopharmaceuticals Sales by Region
8.1.2 Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Region
8.2 Global Nuclear Medicine Radiopharmaceuticals Market Size by Region
8.2.1 Global Nuclear Medicine Radiopharmaceuticals Market Size by Region
8.2.2 Global Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Region
8.3 North America
8.3.1 North America Nuclear Medicine Radiopharmaceuticals Sales by Country
8.3.2 North America Nuclear Medicine Radiopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nuclear Medicine Radiopharmaceuticals Sales by Country
8.4.2 Europe Nuclear Medicine Radiopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales by Region
8.5.2 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nuclear Medicine Radiopharmaceuticals Sales by Country
8.6.2 South America Nuclear Medicine Radiopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Nuclear Medicine Radiopharmaceuticals by Region(2020-2025)
9.2 Global Nuclear Medicine Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Nuclear Medicine Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nuclear Medicine Radiopharmaceuticals Production
9.4.1 North America Nuclear Medicine Radiopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Nuclear Medicine Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nuclear Medicine Radiopharmaceuticals Production
9.5.1 Europe Nuclear Medicine Radiopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Nuclear Medicine Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nuclear Medicine Radiopharmaceuticals Production (2020-2025)
9.6.1 Japan Nuclear Medicine Radiopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Nuclear Medicine Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nuclear Medicine Radiopharmaceuticals Production (2020-2025)
9.7.1 China Nuclear Medicine Radiopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Nuclear Medicine Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cardinal Health
10.1.1 Cardinal Health Basic Information
10.1.2 Cardinal Health Nuclear Medicine Radiopharmaceuticals Product Overview
10.1.3 Cardinal Health Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Basic Information
10.2.2 GE Healthcare Nuclear Medicine Radiopharmaceuticals Product Overview
10.2.3 GE Healthcare Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Jubilant Pharma
10.3.1 Jubilant Pharma Basic Information
10.3.2 Jubilant Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
10.3.3 Jubilant Pharma Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.3.4 Jubilant Pharma Business Overview
10.3.5 Jubilant Pharma SWOT Analysis
10.3.6 Jubilant Pharma Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Nuclear Medicine Radiopharmaceuticals Product Overview
10.4.3 Novartis Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Curium Pharma
10.5.1 Curium Pharma Basic Information
10.5.2 Curium Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
10.5.3 Curium Pharma Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.5.4 Curium Pharma Business Overview
10.5.5 Curium Pharma Recent Developments
10.6 SIEMENS
10.6.1 SIEMENS Basic Information
10.6.2 SIEMENS Nuclear Medicine Radiopharmaceuticals Product Overview
10.6.3 SIEMENS Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.6.4 SIEMENS Business Overview
10.6.5 SIEMENS Recent Developments
10.7 Lantheus
10.7.1 Lantheus Basic Information
10.7.2 Lantheus Nuclear Medicine Radiopharmaceuticals Product Overview
10.7.3 Lantheus Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.7.4 Lantheus Business Overview
10.7.5 Lantheus Recent Developments
10.8 Bracco Imaging
10.8.1 Bracco Imaging Basic Information
10.8.2 Bracco Imaging Nuclear Medicine Radiopharmaceuticals Product Overview
10.8.3 Bracco Imaging Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.8.4 Bracco Imaging Business Overview
10.8.5 Bracco Imaging Recent Developments
10.9 Bayer
10.9.1 Bayer Basic Information
10.9.2 Bayer Nuclear Medicine Radiopharmaceuticals Product Overview
10.9.3 Bayer Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.9.4 Bayer Business Overview
10.9.5 Bayer Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Basic Information
10.10.2 Eli Lilly Nuclear Medicine Radiopharmaceuticals Product Overview
10.10.3 Eli Lilly Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.10.4 Eli Lilly Business Overview
10.10.5 Eli Lilly Recent Developments
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Basic Information
10.11.2 Aurobindo Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
10.11.3 Aurobindo Pharma Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.11.4 Aurobindo Pharma Business Overview
10.11.5 Aurobindo Pharma Recent Developments
10.12 Mundipharma
10.12.1 Mundipharma Basic Information
10.12.2 Mundipharma Nuclear Medicine Radiopharmaceuticals Product Overview
10.12.3 Mundipharma Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.12.4 Mundipharma Business Overview
10.12.5 Mundipharma Recent Developments
10.13 China Isotope and Radiation
10.13.1 China Isotope and Radiation Basic Information
10.13.2 China Isotope and Radiation Nuclear Medicine Radiopharmaceuticals Product Overview
10.13.3 China Isotope and Radiation Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.13.4 China Isotope and Radiation Business Overview
10.13.5 China Isotope and Radiation Recent Developments
10.14 Dongcheng
10.14.1 Dongcheng Basic Information
10.14.2 Dongcheng Nuclear Medicine Radiopharmaceuticals Product Overview
10.14.3 Dongcheng Nuclear Medicine Radiopharmaceuticals Product Market Performance
10.14.4 Dongcheng Business Overview
10.14.5 Dongcheng Recent Developments
11 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast
11.2 Global Nuclear Medicine Radiopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Region
11.2.4 South America Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nuclear Medicine Radiopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Nuclear Medicine Radiopharmaceuticals Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Nuclear Medicine Radiopharmaceuticals by Type (2026-2033)
12.1.2 Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Nuclear Medicine Radiopharmaceuticals by Type (2026-2033)
12.2 Global Nuclear Medicine Radiopharmaceuticals Market Forecast by Application (2026-2033)
12.2.1 Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Medicine Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Nuclear Medicine Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Nuclear Medicine Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Radiopharmaceuticals as of 2024)
Table 10. Global Market Nuclear Medicine Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Nuclear Medicine Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Nuclear Medicine Radiopharmaceuticals Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Nuclear Medicine Radiopharmaceuticals Sales by Type (K MT)
Table 26. Global Nuclear Medicine Radiopharmaceuticals Market Size by Type (M USD)
Table 27. Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) by Type (2020-2025)
Table 28. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 29. Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 30. Global Nuclear Medicine Radiopharmaceuticals Market Size Share by Type (2020-2025)
Table 31. Global Nuclear Medicine Radiopharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 32. Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) by Application
Table 33. Global Nuclear Medicine Radiopharmaceuticals Market Size by Application
Table 34. Global Nuclear Medicine Radiopharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 35. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 36. Global Nuclear Medicine Radiopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 37. Global Nuclear Medicine Radiopharmaceuticals Market Share by Application (2020-2025)
Table 38. Global Nuclear Medicine Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 39. Global Nuclear Medicine Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 40. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 41. Global Nuclear Medicine Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 42. Global Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Table 43. North America Nuclear Medicine Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 44. North America Nuclear Medicine Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Nuclear Medicine Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 46. Europe Nuclear Medicine Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 49. South America Nuclear Medicine Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 50. South America Nuclear Medicine Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 53. Global Nuclear Medicine Radiopharmaceuticals Production (K MT) by Region(2020-2025)
Table 54. Global Nuclear Medicine Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Nuclear Medicine Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 56. Global Nuclear Medicine Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Nuclear Medicine Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Nuclear Medicine Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Nuclear Medicine Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Nuclear Medicine Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Cardinal Health Basic Information
Table 62. Cardinal Health Nuclear Medicine Radiopharmaceuticals Product Overview
Table 63. Cardinal Health Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Cardinal Health Business Overview
Table 65. Cardinal Health SWOT Analysis
Table 66. Cardinal Health Recent Developments
Table 67. GE Healthcare Basic Information
Table 68. GE Healthcare Nuclear Medicine Radiopharmaceuticals Product Overview
Table 69. GE Healthcare Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. GE Healthcare Business Overview
Table 71. GE Healthcare SWOT Analysis
Table 72. GE Healthcare Recent Developments
Table 73. Jubilant Pharma Basic Information
Table 74. Jubilant Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
Table 75. Jubilant Pharma Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Jubilant Pharma Business Overview
Table 77. Jubilant Pharma SWOT Analysis
Table 78. Jubilant Pharma Recent Developments
Table 79. Novartis Basic Information
Table 80. Novartis Nuclear Medicine Radiopharmaceuticals Product Overview
Table 81. Novartis Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Novartis Business Overview
Table 83. Novartis Recent Developments
Table 84. Curium Pharma Basic Information
Table 85. Curium Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
Table 86. Curium Pharma Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Curium Pharma Business Overview
Table 88. Curium Pharma Recent Developments
Table 89. SIEMENS Basic Information
Table 90. SIEMENS Nuclear Medicine Radiopharmaceuticals Product Overview
Table 91. SIEMENS Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. SIEMENS Business Overview
Table 93. SIEMENS Recent Developments
Table 94. Lantheus Basic Information
Table 95. Lantheus Nuclear Medicine Radiopharmaceuticals Product Overview
Table 96. Lantheus Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Lantheus Business Overview
Table 98. Lantheus Recent Developments
Table 99. Bracco Imaging Basic Information
Table 100. Bracco Imaging Nuclear Medicine Radiopharmaceuticals Product Overview
Table 101. Bracco Imaging Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Bracco Imaging Business Overview
Table 103. Bracco Imaging Recent Developments
Table 104. Bayer Basic Information
Table 105. Bayer Nuclear Medicine Radiopharmaceuticals Product Overview
Table 106. Bayer Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Bayer Business Overview
Table 108. Bayer Recent Developments
Table 109. Eli Lilly Basic Information
Table 110. Eli Lilly Nuclear Medicine Radiopharmaceuticals Product Overview
Table 111. Eli Lilly Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Recent Developments
Table 114. Aurobindo Pharma Basic Information
Table 115. Aurobindo Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
Table 116. Aurobindo Pharma Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Aurobindo Pharma Business Overview
Table 118. Aurobindo Pharma Recent Developments
Table 119. Mundipharma Basic Information
Table 120. Mundipharma Nuclear Medicine Radiopharmaceuticals Product Overview
Table 121. Mundipharma Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Mundipharma Business Overview
Table 123. Mundipharma Recent Developments
Table 124. China Isotope and Radiation Basic Information
Table 125. China Isotope and Radiation Nuclear Medicine Radiopharmaceuticals Product Overview
Table 126. China Isotope and Radiation Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. China Isotope and Radiation Business Overview
Table 128. China Isotope and Radiation Recent Developments
Table 129. Dongcheng Basic Information
Table 130. Dongcheng Nuclear Medicine Radiopharmaceuticals Product Overview
Table 131. Dongcheng Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Dongcheng Business Overview
Table 133. Dongcheng Recent Developments
Table 134. Global Nuclear Medicine Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K MT)
Table 135. Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Nuclear Medicine Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 137. North America Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Nuclear Medicine Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 139. Europe Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K MT)
Table 141. Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Nuclear Medicine Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 143. South America Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Nuclear Medicine Radiopharmaceuticals Sales Forecast by Type (2026-2033) & (K MT)
Table 147. Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Nuclear Medicine Radiopharmaceuticals Price Forecast by Type (2026-2033) & (USD/KG)
Table 149. Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) Forecast by Application (2026-2033)
Table 150. Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Medicine Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Nuclear Medicine Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Nuclear Medicine Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Radiopharmaceuticals as of 2024)
Table 10. Global Market Nuclear Medicine Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Nuclear Medicine Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Nuclear Medicine Radiopharmaceuticals Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Nuclear Medicine Radiopharmaceuticals Sales by Type (K MT)
Table 26. Global Nuclear Medicine Radiopharmaceuticals Market Size by Type (M USD)
Table 27. Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) by Type (2020-2025)
Table 28. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 29. Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 30. Global Nuclear Medicine Radiopharmaceuticals Market Size Share by Type (2020-2025)
Table 31. Global Nuclear Medicine Radiopharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 32. Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) by Application
Table 33. Global Nuclear Medicine Radiopharmaceuticals Market Size by Application
Table 34. Global Nuclear Medicine Radiopharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 35. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 36. Global Nuclear Medicine Radiopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 37. Global Nuclear Medicine Radiopharmaceuticals Market Share by Application (2020-2025)
Table 38. Global Nuclear Medicine Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 39. Global Nuclear Medicine Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 40. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 41. Global Nuclear Medicine Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 42. Global Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Table 43. North America Nuclear Medicine Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 44. North America Nuclear Medicine Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Nuclear Medicine Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 46. Europe Nuclear Medicine Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 49. South America Nuclear Medicine Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 50. South America Nuclear Medicine Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 53. Global Nuclear Medicine Radiopharmaceuticals Production (K MT) by Region(2020-2025)
Table 54. Global Nuclear Medicine Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Nuclear Medicine Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 56. Global Nuclear Medicine Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Nuclear Medicine Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Nuclear Medicine Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Nuclear Medicine Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Nuclear Medicine Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Cardinal Health Basic Information
Table 62. Cardinal Health Nuclear Medicine Radiopharmaceuticals Product Overview
Table 63. Cardinal Health Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Cardinal Health Business Overview
Table 65. Cardinal Health SWOT Analysis
Table 66. Cardinal Health Recent Developments
Table 67. GE Healthcare Basic Information
Table 68. GE Healthcare Nuclear Medicine Radiopharmaceuticals Product Overview
Table 69. GE Healthcare Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. GE Healthcare Business Overview
Table 71. GE Healthcare SWOT Analysis
Table 72. GE Healthcare Recent Developments
Table 73. Jubilant Pharma Basic Information
Table 74. Jubilant Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
Table 75. Jubilant Pharma Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Jubilant Pharma Business Overview
Table 77. Jubilant Pharma SWOT Analysis
Table 78. Jubilant Pharma Recent Developments
Table 79. Novartis Basic Information
Table 80. Novartis Nuclear Medicine Radiopharmaceuticals Product Overview
Table 81. Novartis Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Novartis Business Overview
Table 83. Novartis Recent Developments
Table 84. Curium Pharma Basic Information
Table 85. Curium Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
Table 86. Curium Pharma Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Curium Pharma Business Overview
Table 88. Curium Pharma Recent Developments
Table 89. SIEMENS Basic Information
Table 90. SIEMENS Nuclear Medicine Radiopharmaceuticals Product Overview
Table 91. SIEMENS Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. SIEMENS Business Overview
Table 93. SIEMENS Recent Developments
Table 94. Lantheus Basic Information
Table 95. Lantheus Nuclear Medicine Radiopharmaceuticals Product Overview
Table 96. Lantheus Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Lantheus Business Overview
Table 98. Lantheus Recent Developments
Table 99. Bracco Imaging Basic Information
Table 100. Bracco Imaging Nuclear Medicine Radiopharmaceuticals Product Overview
Table 101. Bracco Imaging Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Bracco Imaging Business Overview
Table 103. Bracco Imaging Recent Developments
Table 104. Bayer Basic Information
Table 105. Bayer Nuclear Medicine Radiopharmaceuticals Product Overview
Table 106. Bayer Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Bayer Business Overview
Table 108. Bayer Recent Developments
Table 109. Eli Lilly Basic Information
Table 110. Eli Lilly Nuclear Medicine Radiopharmaceuticals Product Overview
Table 111. Eli Lilly Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Recent Developments
Table 114. Aurobindo Pharma Basic Information
Table 115. Aurobindo Pharma Nuclear Medicine Radiopharmaceuticals Product Overview
Table 116. Aurobindo Pharma Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Aurobindo Pharma Business Overview
Table 118. Aurobindo Pharma Recent Developments
Table 119. Mundipharma Basic Information
Table 120. Mundipharma Nuclear Medicine Radiopharmaceuticals Product Overview
Table 121. Mundipharma Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Mundipharma Business Overview
Table 123. Mundipharma Recent Developments
Table 124. China Isotope and Radiation Basic Information
Table 125. China Isotope and Radiation Nuclear Medicine Radiopharmaceuticals Product Overview
Table 126. China Isotope and Radiation Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. China Isotope and Radiation Business Overview
Table 128. China Isotope and Radiation Recent Developments
Table 129. Dongcheng Basic Information
Table 130. Dongcheng Nuclear Medicine Radiopharmaceuticals Product Overview
Table 131. Dongcheng Nuclear Medicine Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Dongcheng Business Overview
Table 133. Dongcheng Recent Developments
Table 134. Global Nuclear Medicine Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K MT)
Table 135. Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Nuclear Medicine Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 137. North America Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Nuclear Medicine Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 139. Europe Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales Forecast by Region (2026-2033) & (K MT)
Table 141. Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Nuclear Medicine Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (K MT)
Table 143. South America Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Nuclear Medicine Radiopharmaceuticals Sales Forecast by Type (2026-2033) & (K MT)
Table 147. Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Nuclear Medicine Radiopharmaceuticals Price Forecast by Type (2026-2033) & (USD/KG)
Table 149. Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) Forecast by Application (2026-2033)
Table 150. Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nuclear Medicine Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD), 2024-2033
Figure 5. Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD) (2020-2033)
Figure 6. Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Medicine Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nuclear Medicine Radiopharmaceuticals Product Life Cycle
Figure 13. Nuclear Medicine Radiopharmaceuticals Sales Share by Manufacturers in 2024
Figure 14. Global Nuclear Medicine Radiopharmaceuticals Revenue Share by Manufacturers in 2024
Figure 15. Nuclear Medicine Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Nuclear Medicine Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine Radiopharmaceuticals Revenue in 2024
Figure 18. Industry Chain Map of Nuclear Medicine Radiopharmaceuticals
Figure 19. Global Nuclear Medicine Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Nuclear Medicine Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nuclear Medicine Radiopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Nuclear Medicine Radiopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Nuclear Medicine Radiopharmaceuticals by Type in 2024
Figure 29. Market Size Share of Nuclear Medicine Radiopharmaceuticals by Type (2020-2025)
Figure 30. Market Size Share of Nuclear Medicine Radiopharmaceuticals by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nuclear Medicine Radiopharmaceuticals Market Share by Application
Figure 33. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Application in 2024
Figure 35. Global Nuclear Medicine Radiopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Nuclear Medicine Radiopharmaceuticals Market Share by Application in 2024
Figure 37. Global Nuclear Medicine Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Figure 40. North America Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Nuclear Medicine Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 45. U.S. Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nuclear Medicine Radiopharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Nuclear Medicine Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nuclear Medicine Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nuclear Medicine Radiopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Nuclear Medicine Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 55. Germany Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 68. China Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Nuclear Medicine Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 82. Brazil Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nuclear Medicine Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Nuclear Medicine Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Nuclear Medicine Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Nuclear Medicine Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Nuclear Medicine Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Nuclear Medicine Radiopharmaceuticals Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Nuclear Medicine Radiopharmaceuticals Market Share Forecast by Type (2026-2033)
Figure 111. Global Nuclear Medicine Radiopharmaceuticals Sales Forecast by Application (2026-2033)
Figure 112. Global Nuclear Medicine Radiopharmaceuticals Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Nuclear Medicine Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD), 2024-2033
Figure 5. Global Nuclear Medicine Radiopharmaceuticals Market Size (M USD) (2020-2033)
Figure 6. Global Nuclear Medicine Radiopharmaceuticals Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Medicine Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nuclear Medicine Radiopharmaceuticals Product Life Cycle
Figure 13. Nuclear Medicine Radiopharmaceuticals Sales Share by Manufacturers in 2024
Figure 14. Global Nuclear Medicine Radiopharmaceuticals Revenue Share by Manufacturers in 2024
Figure 15. Nuclear Medicine Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Nuclear Medicine Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine Radiopharmaceuticals Revenue in 2024
Figure 18. Industry Chain Map of Nuclear Medicine Radiopharmaceuticals
Figure 19. Global Nuclear Medicine Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Nuclear Medicine Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nuclear Medicine Radiopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Nuclear Medicine Radiopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Nuclear Medicine Radiopharmaceuticals by Type in 2024
Figure 29. Market Size Share of Nuclear Medicine Radiopharmaceuticals by Type (2020-2025)
Figure 30. Market Size Share of Nuclear Medicine Radiopharmaceuticals by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nuclear Medicine Radiopharmaceuticals Market Share by Application
Figure 33. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Application in 2024
Figure 35. Global Nuclear Medicine Radiopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Nuclear Medicine Radiopharmaceuticals Market Share by Application in 2024
Figure 37. Global Nuclear Medicine Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Region (2020-2025)
Figure 40. North America Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Nuclear Medicine Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 45. U.S. Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nuclear Medicine Radiopharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Nuclear Medicine Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nuclear Medicine Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nuclear Medicine Radiopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Nuclear Medicine Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 55. Germany Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 68. China Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Nuclear Medicine Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Country in 2024
Figure 82. Brazil Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nuclear Medicine Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Nuclear Medicine Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nuclear Medicine Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Nuclear Medicine Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Nuclear Medicine Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Nuclear Medicine Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Nuclear Medicine Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Nuclear Medicine Radiopharmaceuticals Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Nuclear Medicine Radiopharmaceuticals Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Nuclear Medicine Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Nuclear Medicine Radiopharmaceuticals Market Share Forecast by Type (2026-2033)
Figure 111. Global Nuclear Medicine Radiopharmaceuticals Sales Forecast by Application (2026-2033)
Figure 112. Global Nuclear Medicine Radiopharmaceuticals Market Share Forecast by Application (2026-2033)
